You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

HomeClinical InformationPerformance MeasuresDiabetes

Diabetes

    Do Not Support: Uncertain Validity
    • Health Plan
    • Integrated Delivery System
    • Population: Regional and State

    Diabetes Screening for People with Schizophrenia or Bipolar Disorder who are Using Antipsychotic Medications (SSD)

    The percentage of patients 18 – 64 years of age with schizophrenia or bipolar disorder, who were dispensed an antipsychotic medication and had a diabetes screening test during the measurement year.

    Date Reviewed: July 21, 2018

    Do Not Support: Uncertain Validity
    • Health Plan
    • Integrated Delivery System

    Comprehensive Diabetes Care: Hemoglobin A1c Control (<8%)

    The percentage of patients 18-75 years of age with diabetes (type 1 and type 2) whose most recent HbA1c level is <8.0% during the measurement year.

    Date Reviewed: July 21, 2018

    Support
    • Group/Practice
    • Health Plan
    • Individual Clinician

    Medical Attention for Nephropathy

    The percentage of patients 18-75 years of age with diabetes (type 1 and type 2) who received a nephropathy screening or monitoring test or had evidence of nephropathy during the measurement year.

    Date Reviewed: November 4, 2018

    Support
    • Group/Practice
    • Health Plan
    • Individual Clinician

    Diabetes: Eye Exam

    The percentage of patients 18-75 years of age with diabetes (type 1 and type 2) who had an eye exam (retinal) performed.

    Date Reviewed: November 4, 2018

    Do Not Support
    • Facility
    • Group/Practice
    • Health Plan
    • Individual Clinician
    • Integrated Delivery System
    • Population: Community, County, or City, Regional and State

    Adults with Diabetes Mellitus That Had a Serum Creatinine in the Last 12 Reported Months

    This measure identifies adults with diabetes mellitus that had a serum creatinine test in last 12 reported months

    Date Reviewed: November 23, 2013

    Support
    • Group/Practice
    • Individual Clinician

    Comprehensive Diabetes Care: Medical Attention for Nephroathy

    The percentage of patients 18-75 years of age with diabetes (type 1 and type 2) who received a nephropathy screening or monitoring test or had evidence of nephropathy during the measurement year.

    Date Reviewed: March 29, 2019

    Do Not Support
    • Health Plan
    • Integrated Delivery System

    Comprehensive Diabetes Care: Hemoglobin A1c (HbA1c) Control (<8.0%)

    The percentage of members 18-75 years of age with diabetes (type 1 and type 2) whose most recent HbA1c level is <8.0% during the measurement year.

    Date Reviewed: April 27, 2015

    Support
    • Health Plan

    Comprehensive Diabetes Care: Hemoglobin A1c (HbA1c) Testing

    The percentage of patients 18-75 years of age with diabetes (type 1 and type 2) who received an HbA1c test during the measurement year.

    Date Reviewed: November 7, 2015

    Do Not Support
    • Group/Practice
    • Individual Clinician

    Diabetic Foot & Ankle Care, Peripheral Neuropathy-Neurological Evaluation

    Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who had a neurological examination of their lower extremities within 12 months.

    Date Reviewed: November 19, 2017

    Do Not Support
    • Group/Practice
    • Individual Clinician

    Diabetic Foot & Ankle Care, Ulcer Prevention-Evaluation of Footwear

    Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who were evaluated for proper footwear and sizing.

    Date Reviewed: November 19, 2017

    Pages

    As part of an ongoing effort to improve user experience, we have made some updates to the Performance Measures section of ACP. Tell us what you think!